The Financial Times reports today that Medline is planning to set its initial public offering (IPO) at up to $7 billion.
Medline Inc. (“Medline”) announced today the pricing of its upsized initial public offering of 216,034,482 shares of its Class A common stock, at a public offering price of $29.00 per share. Medline ...
The breast lesion localization devices market is showing consistent expansion, with an estimated compound annual growth rate of approximately 7% over the forecast period. This growth is fueled by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results